# FDA 483 - Christina S. Baik, M.D. - June 03, 2020

Source: https://www.globalkeysolutions.net/records/483/christina-s-baik-md/90e31e01-1d87-42ee-a4c3-be217534be2d

> FDA 483 for Christina S. Baik, M.D. on June 03, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Christina S. Baik, M.D.
- Inspection Date: 2020-06-03
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West VI
- Summary: An FDA inspection of Christina S. Baik, M.D., a clinical investigator in Seattle, WA, revealed a significant deviation from an investigational plan. Specifically, a subject who met exclusion criteria was improperly enrolled and administered a study drug. This indicates a failure to adhere to study protocols and investigator responsibilities.

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)

Company: https://www.globalkeysolutions.net/companies/christina-s-baik-md/6971ef0b-0bc2-4a69-b07f-1f3771ce292d

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-vi/6e5a2a08-f464-4979-a759-7b0383370822